These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 30289574

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Increased frequency of skin-infiltrating FoxP3+ regulatory T cells as a diagnostic indicator of severe atopic dermatitis from cutaneous T cell lymphoma.
    Hanafusa T, Matsui S, Murota H, Tani M, Igawa K, Katayama I.
    Clin Exp Immunol; 2013 Jun; 172(3):507-12. PubMed ID: 23600840
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity.
    Kakinuma T, Nakamura K, Wakugawa M, Mitsui H, Tada Y, Saeki H, Torii H, Asahina A, Onai N, Matsushima K, Tamaki K.
    J Allergy Clin Immunol; 2001 Mar; 107(3):535-41. PubMed ID: 11240957
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Erythrodermic cutaneous T-cell lymphoma: how to differentiate this rare disease from atopic dermatitis.
    Miyagaki T, Sugaya M.
    J Dermatol Sci; 2011 Oct; 64(1):1-6. PubMed ID: 21872448
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Interleukin-17A-induced production of acute serum amyloid A by keratinocytes contributes to psoriasis pathogenesis.
    Couderc E, Morel F, Levillain P, Buffière-Morgado A, Camus M, Paquier C, Bodet C, Jégou JF, Pohin M, Favot L, Garcia M, Huguier V, Mcheik J, Lacombe C, Yssel H, Guillet G, Bernard FX, Lecron JC.
    PLoS One; 2017 Oct; 12(7):e0181486. PubMed ID: 28708859
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cutaneous T cell lymphoma complicating severe atopic dermatitis. Is making a diagnosis the main challenge?
    Meyer N, Mazereeuw-Hautier J, Launay F, Lamant L, Paul C.
    Dermatology; 2009 Oct; 218(2):168-71. PubMed ID: 19060456
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: A retrospective cohort study.
    Hasan I, Parsons L, Duran S, Zinn Z.
    J Am Acad Dermatol; 2024 Aug; 91(2):255-258. PubMed ID: 38588818
    [Abstract] [Full Text] [Related]

  • 19. Atopy, IgE and eosinophilic cationic protein concentration, specific IgE positivity, eosinophil count in cutaneous T Cell lymphoma.
    Kural YB, Su O, Onsun N, Uras AR.
    Int J Dermatol; 2010 Apr; 49(4):390-5. PubMed ID: 20465692
    [Abstract] [Full Text] [Related]

  • 20. Sézary Syndrome and Atopic Dermatitis: Comparison of Immunological Aspects and Targets.
    Saulite I, Hoetzenecker W, Weidinger S, Cozzio A, Guenova E, Wehkamp U.
    Biomed Res Int; 2016 Apr; 2016():9717530. PubMed ID: 27294147
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.